Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mangoceuticals (MGRX) Return on Capital Employed (2023 - 2025)

Mangoceuticals (MGRX) has disclosed Return on Capital Employed for 3 consecutive years, with 1.17% as the latest value for Q4 2025.

  • Quarterly Return on Capital Employed fell 59.0% to 1.17% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1.17% through Dec 2025, down 59.0% year-over-year, with the annual reading at 1.22% for FY2025, 4.0% down from the prior year.
  • Return on Capital Employed hit 1.17% in Q4 2025 for Mangoceuticals, down from 1.08% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 3.25% in Q1 2024 to a low of 1.74% in Q4 2023.
  • Historically, Return on Capital Employed has averaged 0.33% across 3 years, with a median of 0.61% in 2025.
  • Biggest five-year swings in Return on Capital Employed: surged 116bps in 2024 and later plummeted -386bps in 2025.
  • Year by year, Return on Capital Employed stood at 1.74% in 2023, then soared by 66bps to 0.58% in 2024, then plummeted by -100bps to 1.17% in 2025.
  • Business Quant data shows Return on Capital Employed for MGRX at 1.17% in Q4 2025, 1.08% in Q3 2025, and 0.69% in Q2 2025.